> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Determines ANDA Eligibility for Sodium Iodide
- URL: https://www.fdaweb.com/fda-determines-anda-eligibility-for-sodium-iodide/
- Published: 2018-05-11T12:00:00.000Z
- Updated: 2026-09-15T00:04:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141420

*Federal Register* notice: FDA has determined that GE Healthcare’s sodium iodide I 123 oral solution, 2 millicuries/milliliter was not withdrawn from sale due to safety or effectiveness. The determination will allow FDA to approve ANDAs that cite this reference product. The FDA determination was made in response to an International Isotopes 2017 citizen petition. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-05-11/pdf/2018-10099.pdf?ref=fdaweb.com).